Activ’Inside will launch at Vitafoods Europe 2016 its new synergistic bioavailable solution, Memophenol, which has clinically demonstrated to improve learning, working memory and long-term memory.
Memophenol is composed of French grape (Vitis vinifera) and wild blueberry (Vaccinium angustifolium) extracts, specific ingredients with scientifically proven beneficial effects on learning and memory impairments. The product is a French proprietary, patent-pending solution.
Memophenol has been evaluated in a large-scale, bi-center, randomized, double-blind, placebo-controlled clinical study. The trial was conducted for 6 months on more than 200 people, based on CANTAB tests from Cambridge Cognition (Verbal Recall Memory test and Paired Associated Learning test).
Memophenol was shown to:
- Reduce short-term memory loss, with the Memophenol group forgetting 2.5 times fewer words than the placebo group.
- Improve long-term memory performances; people taking Memophenol made half the memory errors, compared to the placebo group, after 6 months of supplementation.
- Reverse up to 10 years of brain aging, as the Memophenol group's score corresponded to a cognitive age of 50 to 59 years, whereas those in the placebo group maintained a mean score equivalent to people between 60 to 69 years old.
Memophenol is the fruit of a four-year international research program, the Neurophenols Consortium. Its development is based on a large scientific support with strong literature and preclinical studies.
Memophenol's effects result both from a high demonstrated bioavailability of the solution, as active molecules have been found in animal brain, and from a synergistic action as Memophenol has shown to increase by five-fold the absorption of raw materials metabolites, versus individual extracts. The solution has revealed complementary mechanisms of actions on brain plasticity, neurogenesis, brain microcirculation and oxidative balance.